Format

Send to

Choose Destination
Transgenic Res. 2014 Aug;23(4):691-5. doi: 10.1007/s11248-014-9802-3. Epub 2014 May 6.

Improved pregnancy and birth rates with routine application of nonsurgical embryo transfer.

Author information

1
MCCA Transgenic Core Facility, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.

Abstract

Nonsurgical embryo transfer (NSET) of blastocysts to pseudopregnant female recipients provides many benefits over surgical implantation with less distress for the mice, no anesthesia or analgesia required and a considerable reduction in implantation time per mouse. Although a disposable device to perform NSET is on the market since 2009, it is not generally used in transgenic facilities, most likely because surgical implantation is efficient and inexpensive. Here, we report that with several refinements to the original protocol, the NSET method becomes very attractive and outperforms the traditional surgical transfer on basis of pregnancy rate, birth rate and implantation-related discomfort. Furthermore, repeated use of the same NSET device on several recipient females reduces the costs to a reasonable level. The data presented covers all embryo transfers over the last 5 years at the transgenic facility of the Netherlands Cancer Institute, of which the last 2 years were performed exclusively with NSET.

PMID:
24798251
PMCID:
PMC4053600
DOI:
10.1007/s11248-014-9802-3
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center